Expression of LGR-5, MSI-1 and DCAMKL-1, putative stem cell markers, in the early phases of 1,2-dimethylhydrazine-induced rat colon carcinogenesis: Correlation with nuclear β-catenin

BMC Cancer

Volumn 13, Issue , 2013, Pages

  Femia, Angelo Pietro ^a   Dolara, Piero ^a   Salvadori, Maddalena ^a   Caderni, Giovanna ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Colon carcinogenesis; Precancerous lesions; Stem cells

Indexed keywords

1,2 DIMETHYLHYDRAZINE; BETA CATENIN; CELECOXIB; CELL MARKER; DOUBLECORTIN AND CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE LIKE 1; G PROTEIN COUPLED RECEPTOR; LEUCINE RICH REPEAT CONTAINING G PROTEIN COUPLED RECEPTOR 5; MUSASHI 1 PROTEIN; PHOSPHOTRANSFERASE; PROSTAGLANDIN E2; RNA BINDING PROTEIN; UNCLASSIFIED DRUG;

ADENOMA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER STEM CELL; CELL NUCLEUS; CELL SUBPOPULATION; COLON CARCINOGENESIS; COLON MUCOSA; CONTROLLED STUDY; INTESTINE CRYPT; LABELING INDEX; MALE; MUCIN DEPLETED FOCI; NONHUMAN; PRECANCER; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT;

1,2-DIMETHYLHYDRAZINE; ADENOMA; ANIMALS; BETA CATENIN; CELL NUCLEUS; CELL TRANSFORMATION, NEOPLASTIC; COLONIC NEOPLASMS; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; DINOPROSTONE; FLUORESCENT ANTIBODY TECHNIQUE; IMMUNOHISTOCHEMISTRY; INTESTINAL MUCOSA; MALE; NEOPLASTIC STEM CELLS; NERVE TISSUE PROTEINS; PRECANCEROUS CONDITIONS; PROTEIN-SERINE-THREONINE KINASES; PYRAZOLES; RATS; RATS, INBRED F344; RECEPTORS, G-PROTEIN-COUPLED; RNA-BINDING PROTEINS; SULFONAMIDES; TIME FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 84873051147     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-13-48     Document Type: Article

References (45)

1. Todaro M, Francipane MG, Medema JP, Stassi G. Colon cancer stem cells: promise of targeted therapy. Gastroenterology 2010, 138(6):2151-62. 10.1053/j.gastro.2009.12.063, 20420952.
2. Marshman E, Booth C, Potten CS. The intestinal epithelial stem cell. Bioessays 2002, 24(1):91-8. 10.1002/bies.10028, 11782954.
3. Clevers H. The cancer stem cell: premises, promises and challenges. Nat Med 2011, 17(3):313-9.
4. Vermeulen L, Sprick MR, Kemper K, Stassi G, Medema JP. Cancer stem cells-old concepts, new insights. Cell Death Differ 2008, 15(6):947-58. 10.1038/cdd.2008.20, 18259194.
5. Corpet DE, Pierre F. How good are rodent models of carcinogenesis in predicting efficacy in humans? A systematic review and meta-analysis of colon chemoprevention in rats, mice and men. Eur J Cancer 2005, 41:1911-22. 10.1016/j.ejca.2005.06.006, 16084718.
6. Femia AP, Caderni G. Rodent models of colon carcinogenesis for the study of chemopreventive activity of natural products. Planta Med 2008, 74(13):1602-7. 10.1055/s-2008-1074577, 18604780.
7. Femia AP, Bendinelli B, Giannini A, Salvadori M, Pinzani P, Dolara P, Caderni G. Mucin-depleted foci have beta-catenin gene mutations, altered expression of its protein, and are dose- and time-dependent in the colon of 1,2-dimethylhydrazine-treated rats. Int J Cancer 2005, 116(1):9-15. 10.1002/ijc.20981, 15751047.
8. Femia AP, Dolara P, Giannini A, Salvadori M, Biggeri A, Caderni G. Frequent mutation of Apc gene in rat colon tumours and mucin-depleted foci, preneoplastic lesions in experimental colon carcinogenesis. Cancer Res 2007, 67(2):445-9. 10.1158/0008-5472.CAN-06-3861, 17234750.
9. Barker N, Clevers H. Mining the Wnt pathway for cancer therapeutics. Nat Rev Drug Discov 2006, 5(12):997-1014. 10.1038/nrd2154, 17139285.
10. Le NH, Franken P, Fodde R. Tumour -stroma interactions in colorectal cancer: converging on β-catenin activation and cancer stemness. Br J Cancer 2008, 98(12):1886-93. 10.1038/sj.bjc.6604401, 2441948, 18506144.
11. Vermeulen L, De Sousa E, Melo F, van der Heijden M, Cameron K, de Jong JH, Borovski T, Tuynman JB, Todaro M, Merz C, Rodermond H, Sprick MR, Kemper K, Richel DJ, Stassi G, Medema JP. Wnt activity defines colon cancer stem cells and is regulated by the microenvironment. Nat Cell Biol 2010, 12(5):468-76. 10.1038/ncb2048, 20418870.
12. Fodde R, Brabletz T. Wnt/beta-catenin signaling in cancer stemness and malignant behavior. Curr Opin Cell Biol 2007, 19(2):150-8. 10.1016/j.ceb.2007.02.007, 17306971.
13. Castellone MD, Teramoto H, Williams BO, Druey KM, Gutkind JS. Prostaglandin E2 promotes colon cancer cell growth through a Gs-axin-β-catenin signaling axis. Science 2005, 310(5753):1504-10. 10.1126/science.1116221, 16293724.
14. Dalerba P, Dylla SJ, Park IK, Liu R, Wang X, Cho RW, Hoey T, Gurney A, Huang EH, Simeone DM, Shelton AA, Parmiani G, Castelli C, Clarke MF. Phenotypic characterization of human colorectal cancer stem cells. Proc Natl Acad Sci USA 2007, 104(24):10158-63. 10.1073/pnas.0703478104, 1891215, 17548814.
15. Du L, Wang H, He L, Zhang J, Ni B, Wang X, Jin H, Cahuzac N, Mehrpour M, Lu Y, Chen Q. CD44 is of functional importance for colorectal cancer stem cells. Clin Cancer Res 2008, 14(21):6751-60. 10.1158/1078-0432.CCR-08-1034, 18980968.
16. Potten CS, Booth C, Tudor GL, Booth D, Brady G, Hurley P, Ashton G, Clarke R, Sakakibara S, Okano H. Identification of a putative intestinal stem cell and early lineage marker; musashi-1. Differentiation 2003, 71(1):28-41. 10.1046/j.1432-0436.2003.700603.x, 12558601.
17. Ricci-Vitiani L, Lombardi DG, Pilozzi E, Biffoni M, Todaro M, Peschle C, De Maria R. Identification and expansion of human colon-cancer-initiating cells. Nature 2007, 445(7123):111-5. 10.1038/nature05384, 17122771.
18. May R, Riehl TE, Hunt C, Sureban SM, Anant S, Houchen CW. Identification of a novel putative gastrointestinal stem cell and adenoma stem cell marker, doublecortin and CaM kinase-like-1, following radiation injury and in adenomatous polyposis coli/multiple intestinal neoplasia mice. Stem Cells 2008, 26(3):630-7. 10.1634/stemcells.2007-0621, 18055444.
19. Huang EH, Hynes MJ, Zhang T, Ginestier C, Dontu G, Appelman H, Fields JZ, Wicha MS, Boman BM. Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumourigenesis. Cancer Res 2009, 69(8):3382-9. 10.1158/0008-5472.CAN-08-4418, 2789401, 19336570.
20. Powell AE, Wang Y, Li Y, Poulin EJ, Means AL, Washington MK, Higginbotham JN, Juchheim A, Prasad N, Levy SE, Guo Y, Shyr Y, Aronow BJ, Haigis KM, Franklin JL, Coffey RJ. The pan-ErbB negative regulator Lrig1 is an intestinal stem cell marker that functions as a tumour suppressor. Cell 2012, 149(1):146-58. 10.1016/j.cell.2012.02.042, 22464327.
21. Barker N, van Es JH, Kuipers J, Kujala P, Van Den Born M, Cozijnsen M, Haegebarth A, Korving J, Begthel H, Peters PJ, Clevers H. Identification of stem cells in small intestine and colon by marker gene LGR-5. Nature 2007, 449(7165):1003-7. 10.1038/nature06196, 17934449.
22. Li L, Clevers H. Coexistence of quiescent and active adult stem cells in mammals. Science 2010, 327(5965):542-5. 10.1126/science.1180794, 20110496.
23. Femia AP, Luceri C, Toti S, Giannini A, Dolara P, Caderni G. Gene expression profile and genomic alterations in colonic tumours induced by 1,2-dimethylhydrazine (DMH) in rats. BMC Cancer 2010, 11:10-194.
24. Goessling W, North TE, Loewer S, Lord AM, Lee S, Stoick-Cooper CL, Weidinger G, Puder M, Daley GQ, Moon RT, Zon LI. Genetic interaction of PGE2 and Wnt signaling regulates developmental specification of stem cells and regeneration. Cell 2009, 136(6):1136-47. 10.1016/j.cell.2009.01.015, 2692708, 19303855.
25. European Community: European Community Regulations on the Care and Use of Laboratory Animals (1986) (Law 86/609/EC
26. Femia AP, Caderni G, Bottini C, Salvadori M, Dolara P, Tessitore L. Mucin-depleted foci are modulated by dietary treatments and show deregulation of proliferative activity in carcinogen-treated rodents. Int J Cancer 2007, 120(11):2301-5. 10.1002/ijc.22145, 17294441.
27. Femia AP, Luceri C, Dolara P, Giannini A, Biggeri A, Salvadori M, Clune Y, Collins KJ, Paglierani M, Caderni G. Antitumourigenic activity of the prebiotic inulin enriched with oligofructose in combination with the probiotics Lactobacillus rhamnosus and Bifidobacterium lactis on azoxymethane-induced colon carcinogenesis in rats. Carcinogenesis 2002, 23(11):1953-60. 10.1093/carcin/23.11.1953, 12419846.
28. Fan XS, Wu HY, Yu HP, Zhou Q, Zhang YF, Huang Q. Expression of LGR-5 in human colorectal carcinogenesis and its potential correlation with beta-catenin. Int J Colorectal Dis 2010, 25(5):583-90. 10.1007/s00384-010-0903-z, 20195621.
29. Kleist B, Xu L, Li G, Kersten C. Expression of the adult intestinal stem cell marker Lgr5 in the metastatic cascade of colorectal cancer. Int J Clin Exp Pathol 2011, 4(4):327-35. 3093057, 21577318.
30. Barker N, Ridgway RA, van Es JH, van de Wetering M, Begthel H, Van Den Born M, Danenberg E, Clarke AR, Sansom OJ, Clevers H. Crypt stem cells as the cells-of-origin of intestinal cancer. Nature 2009, 457(7229):608-11. 10.1038/nature07602, 19092804.
31. Uchida H, Yamazaki K, Fukuma M, Yamada T, Hayashida T, Hasegawa H, Kitajima M, Kitagawa Y, Sakamoto M. Overexpression of leucine-rich repeat-containing G protein-coupled receptor 5 in colorectal cancer. Cancer Sci 2010, 101(7):1731-7. 10.1111/j.1349-7006.2010.01571.x, 20384634.
32. Nishimura S, Wakabayashi N, Toyoda K, Kashima K, Mitsufuji S. Expression ofMusashi-1 in human normal colon crypt cells: a possible stem cell marker of human colon epithelium. Dig Dis Sci 2003, 48(8):1523-9. 10.1023/A:1024763723240, 12924647.
33. Gerbe F, Brulin B, Makrini L, Legraverend C, Jay P. DCAMKL-1 expression identifies Tuft cells rather than stem cells in the adult mouse intestinal epithelium. Gastroenterology 2009, 137(6):2179-80. 10.1053/j.gastro.2009.06.072, 19879217.
34. Gerbe F, van Es JH, Makrini L, Brulin B, Mellitzer G, Robine S, Romagnolo B, Shroyer NF, Bourgaux JF, Pignodel C, Clevers H, Jay P. Distinct ATOH1 and Neurog3 requirements define tuft cells as a new secretory cell type in the intestinal epithelium. J Cell Biol 2011, 192(5):767-80. 10.1083/jcb.201010127, 3051826, 21383077.
35. Nabeyama A, Leblond CP. "Caveolated cells" characterized by deep surface invaginations and abundant filaments in mouse gastro-intestinal epithelia. Am J Anat 1974, 140(2):147-65. 10.1002/aja.1001400203, 4363601.
36. Sureban SM, May R, Ramalingam S, Subramaniam D, Natarajan G, Anant S, Houchen CW. Selective blockade of DCAMKL-1 results in tumour growth arrest by a Let-7a MicroRNA-dependent mechanism. Gastroenterology 2009, 137(2):649-59. 10.1053/j.gastro.2009.05.004, 2775069, 19445940.
37. Ruder EH, Laiyemo AO, Graubard BI, Hollenbeck AR, Schatzkin A, Cross AJ. Non-steroidal anti-inflammatory drugs and colorectal cancer risk in a large, prospective cohort. Am J Gastroenterol 2011, 106(7):1340-50. 10.1038/ajg.2011.38, 3183504, 21407185.
38. Fischer SM, Hawk ET, Lubet RA. Coxibs and other nonsteroidal anti-inflammatory drugs in animal models of cancer chemoprevention. Cancer Prev Res (Phila) 2011, 4(11):1728-35.
39. Liao X, Lochhead P, Nishihara R, Morikawa T, Kuchiba A, Yamauchi M, Imamura Y, Qian ZR, Baba Y, Shima K, Sun R, Nosho K, Meyerhardt JA, Giovannucci E, Fuchs CS, Chan AT, Ogino S. Aspirin use, tumor PIK3CA mutation, and colorectal-cancer survival. N Engl J Med 2012, 367(17):1596-606. 10.1056/NEJMoa1207756, 23094721.
40. Greenspan EJ, Madigan JP, Boardman LA, Rosenberg DW. Ibuprofen inhibits activation of nuclear {beta}-catenin in human colon adenomas and induces the phosphorylation of GSK-3{beta}. Cancer Prev Res (Phila) 2011, 4(1):161-71.
41. Brown WA, Skinner SA, Vogiagis D, O'Brien PE. Inhibition of beta-catenintranslocation in rodent colorectal tumours: a novel explanation for theprotective effect of nonsteroidal antiinflammatory drugs in colorectal cancer. Dig Dis Sci 2001, 46(11):2314-21. 10.1023/A:1012326525692, 11713928.
42. Lönnroth C, Andersson M, Nordgren S, Lundholm K. Downregulation of Prominin1/CD133 expression in colorectal cancer by NSAIDs following short-term preoperative treatment. Int J Oncol 2012, 41(1):15-23.
43. Qiu W, Wang X, Leibowitz B, Liu H, Barker N, Okada H, Oue N, Yasui W, Clevers H, Schoen RE, Yu J, Zhang L. Chemoprevention by nonsteroidal anti-inflammatory drugs eliminates oncogenic intestinal stem cells via SMAC-dependent apoptosis. Proc Natl Acad Sci USA 2010, 107(46):20027-32. 10.1073/pnas.1010430107, 2993406, 21041628.
44. Reddy BS, Patlolla JM, Simi B, Wang SH, Rao CV. Prevention of colon cancer by low doses of celecoxib, a cyclooxygenase inhibitor, administered in diet rich in omega-3 polyunsaturated fatty acids. Cancer Res 2005, 65(17):8022-7.
45. Tuynman JB, Vermeulen L, Boon EM, Kemper K, Zwinderman AH, Peppelenbosch MP, Richel DJ. Cyclooxygenase-2 inhibition inhibits c-Met kinase activity and Wnt activity in colon cancer. Cancer Res 2008, 68(4):1213-20. 10.1158/0008-5472.CAN-07-5172, 18281498.